Varian Medical Systems
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Varian Medical Systems's revenues will grow 5.2% and EPS will grow 6.3%.
The average estimate for revenue is $758.0 million. On the bottom line, the average EPS estimate is $1.02.
Last quarter, Varian Medical Systems logged revenue of $678.4 million. GAAP reported sales were 8.5% higher than the prior-year quarter's $625.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.89. GAAP EPS of $0.86 for Q1 were 8.9% higher than the prior-year quarter's $0.79 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.9%, 10 basis points worse than the prior-year quarter. Operating margin was 20.9%, 30 basis points better than the prior-year quarter. Net margin was 14.0%, 40 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.04 billion. The average EPS estimate is $4.12.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 386 members out of 401 rating the stock outperform, and 15 members rating it underperform. Among 115 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 112 give Varian Medical Systems a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Varian Medical Systems is outperform, with an average price target of $72.71.
Is Varian Medical Systems the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Varian Medical Systems to My Watchlist.